US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.04

0.0000

Volume:128

Turnover:4.20K

Market Cap:13.22M

PE:- -

High:33.04

Open:33.04

Low:33.04

Close:33.04

52wk High:34.86

52wk Low:25.79

Shares:400.00K

Float Shares:400.00K

Volume Ratio:0.06

T/O Rate:0.03%

Dividend:0.08

Dividend Rate:0.25%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout

Johnson & Johnson Announces R$ 0.3 Per Unit Dividend for 3Q 2026

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses

THOMSON REUTERS

Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment

Edwards Lifesciences (EW) Gets a Buy from Citi

Hybio Pharmaceutical Advances Obesity Treatment with New Triple Agonist Clinical Trial Filing

AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients

Bank of America Reveals 5.22% Indirect Stake in Qiagen

Merck Price Target Raised to $161.00/Share from $127.00 by Leerink Partners

Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress

Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting

Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247

Leerink Partners Adjusts Price Target on Merck & Co. to $161 From $127, Keeps Outperform Rating

MT Newswires Live

Merck & Co Inc : Leerink Partners Raises Target Price to $161 from $127

THOMSON REUTERS

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection

Merck price target raised to $161 from $127 at Leerink

Genfit Targets Billion‑Dollar MASH Diagnostics Market With NISTM Blood Tests

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/BMED/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.0422,"timestamp":1789061764176,"preClose":33.0422,"halted":0,"volume":128,"delay":0,"changeRate":0,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-10 14:07:06 EDT","open":33.0422,"high":33.0422,"low":33.0422,"amount":4204.9024,"amplitude":0,"askPrice":32.84,"askSize":1000,"bidPrice":32.76,"bidSize":1000,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":33.0422,"sharesOutstanding":360000,"nav":33.299049,"aum":13319619.6,"dividendRate":0.0025,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.1599,"preClose":33.0422,"latestTime":"16:10 EDT","volume":6,"amount":198.2532,"timestamp":1788984604450,"change":0.1177,"changeRate":0.003562,"amplitude":0},"volumeRatio":0.064649,"impliedVol":0.2836,"impliedVolPercentile":0.761},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.064649,"shares":400000,"dividePrice":0.0826,"high":33.0422,"amplitude":0,"preClose":33.0422,"low":33.0422,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":33.0422,"eps":0,"divideRate":0.0025,"volume":128,"delay":0,"ttmEps":0,"open":33.0422,"prevYearClose":30.32,"prevWeekClose":34.0304,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":34.2802,"twentyDayClose":32.4518,"sixtyDayClose":28.4821},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666659414","title":"Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout","url":"https://stock-news.laohu8.com/highlight/detail?id=2666659414","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666659414?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:04","pubTimestamp":1789052640,"startTime":"0","endTime":"0","summary":"Wachtell dealmaker jumps to Linklaters to bolster US buildoutSept 10 (Reuters)-Law firm Linklaters said on Thursday that it has hired longtime partner Mark Gordon from Wachtell, Lipton, Rosen & Katz, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL6N4520WA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210536198.USD","IYH","XLV","LU0496365809.HKD","IE00BDGV0183.EUR","LU1084165304.USD","BMED","LU0689472784.USD","RXL","IE00BVYPNW00.USD","GDOC","LU1355424745.HKD","LU1989771016.USD","LU2293690082.USD","LU0053666078.USD","IHE","LU1829250122.USD","JDOC","LU1880407215.USD","FTXH","LU0466842654.USD","LU2089284900.SGD","IE00B3PB1722.GBP","JHX","03165","LU1323610961.USD","LU2430703095.HKD","PJP","LU2089283258.USD","MEDX","LU0708994859.HKD","LU0072461881.USD","LU2112291526.USD","JNJ","LU2750360997.AUD","LU0960981461.USD","FHLC","LU0972486137.USD","IE000SO60NU8.SGD","IXJ","LU0211326839.USD","VHT","IE00B4R5TH58.HKD","LU1291159041.SGD","LU0077335932.USD","IE00BLSP4452.SGD","LU1814569148.SGD","LU0949170426.SGD","AZN.UK","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666591236","title":"Johnson & Johnson Announces R$ 0.3 Per Unit Dividend for 3Q 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666591236","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666591236?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:31","pubTimestamp":1789050684,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announces R$ 0.3 per unit dividend for 3Q 2026Johnson & Johnson declared a dividend of R$ 0.3 per unit for the third quarter of 2026.Last day to trade with dividend rights is Aug. 24","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL8Bmdh0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","BMED","RXL","LU0683600562.USD","LU1066051225.USD","PJP","LU2023250330.USD","FHLC","LU2750360997.AUD","LU2750360641.GBP","LU0426417589.USD","IE0002141913.USD","LU1057294990.SGD","LU2602419157.SGD","LU1506573853.SGD","LU0289739699.SGD","IE00B19Z3B42.SGD","IYH","LU2133065610.SGD","MEDX","IE00BVYPNV92.GBP","SG9999001440.SGD","XLV","GDOC","IXJ","VHT","LU0345769128.USD","IE000M9KFDE8.USD","LU1280957306.USD","LU2471134952.CNY","LU0640476718.USD","LU0795875086.SGD","LU2471134879.HKD","LU1267930813.SGD","LU1244550494.USD","IE00BVYPNW00.USD","JDOC","IE000SO60NU8.SGD","IE00BFXG1179.USD","TRUH","LU1074936037.SGD","IHE","LU0053666078.USD","BK4007","FTXH","JNJ","LU2430703251.USD","LU0320765646.SGD","IE00B3T34201.USD","LU0345769631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666598426","title":"Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598426","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666598426?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:50","pubTimestamp":1789041051,"startTime":"0","endTime":"0","summary":"Johnson & Johnson has received CE Marking for ACUVUE OASYS MAX 2-Week, a new reusable contact lens featuring proprietary MAX technologies designed ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-receives-ce-marking-for-acuvue-oasys-max-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-receives-ce-marking-for-acuvue-oasys-max-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","SGXZ57979304.SGD","BK4078","IE00B7SZLL34.SGD","LU2750360641.GBP","LU0345770308.USD","TRUH","IE00B3PB1722.GBP","IE000M9KFDE8.USD","LU1228905037.USD","MAX","IE00B2B36J28.USD","SG9999002232.USD","IE00BVYPNW00.USD","MEDX","IE0000B7K699.USD","LU1929549753.HKD","LU0345769631.USD","LU2471134952.CNY","LU0203347892.USD","LU0689626769.HKD","IE00BDGV0183.EUR","GPRO","PJP","IE00BLSP4452.SGD","JDOC","IE00BSNM7G36.USD","BK4533","BK4559","LU0320765646.SGD","LU0787776722.HKD","VHT","LU1894683264.USD","RXL","JNJ","LU0234570918.USD","LU1066053197.SGD","IHE","FHLC","BK4581","BMED","XLV","IYH","LU1032955483.USD","LU0943347566.SGD","LU1280957306.USD","IE000MB6IJN5.SGD","FTXH","IXJ","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666598631","title":"Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598631","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666598631?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:45","pubTimestamp":1789040700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA26VGSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2592432038.USD","LU1032466523.USD","LU0320765646.SGD","TRUH","LU0345770308.USD","LU0432979614.USD","LU2602419157.SGD","IE00BJT1NW94.SGD","LU1261432733.SGD","LU2129689605.HKD","LU1032955483.USD","LU1043141396.HKD","PJP","BK4504","IE000WAW04H5.SGD","BK4533","RXL","LU2089984988.USD","JNJ","IE00B4R5TH58.HKD","IE00BVYPNW00.USD","BK4559","IYH","IE00BBT3K403.USD","LU0058720904.USD","LU0466842654.USD","LU1935042991.SGD","BMED","MEDX","VHT","LU1291159041.SGD","LU1057294990.SGD","BK4550","LU1506573853.SGD","FHLC","LU2487616109.SGD","GDOC","SGXZ57979304.SGD","FTXH","IHE","IE00BFXG1179.USD","IE00BLSP4239.USD","LU1074936037.SGD","LU1280957306.USD","XLV","IXJ","LU1894683264.USD","LU2750360641.GBP","LU2023250330.USD","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560042","title":"Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560042","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560042?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:15","pubTimestamp":1789038900,"startTime":"0","endTime":"0","summary":"Capital will support continued CNSide commercial scale-up and development Initial tranche of funding provided at closing with future tranches linked to milestones Forecasted cash runway now into 2028 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359376/0/en/cerenome-announces-up-to-20-million-financing-facility-with-royalty-based-repayment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666968562","title":"Edwards Lifesciences (EW) Gets a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666968562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666968562?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:16","pubTimestamp":1789035394,"startTime":"0","endTime":"0","summary":"Citi analyst Joanne Wuensch maintained a Buy rating on Edwards Lifesciences today and set a price target of $110.00. Wuensch covers the Healthcare ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/edwards-lifesciences-ew-gets-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/edwards-lifesciences-ew-gets-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BMED","LU0345774391.USD","IE00BYQQ9H92.USD","BK4585","IE00BN0W2T93.GBP","SGXZ57979304.SGD","IE00BN0W2W23.USD","XLV","SG9999001176.SGD","LU0823416689.USD","IHI","SG9999013999.USD","BK4082","LABU","LU0058720904.USD","BK4504","IE00BN0W2V16.EUR","AGNG","XBI","SG9999001176.USD","EW","IE00BFXG0V08.USD","LU0345774631.USD","BK4567","BK4588","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198884233","title":"Hybio Pharmaceutical Advances Obesity Treatment with New Triple Agonist Clinical Trial Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=1198884233","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198884233?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:28","pubTimestamp":1789028880,"startTime":"0","endTime":"0","summary":"Hybio Pharmaceutical Co.,Ltd. (300199.SZ) has announced the receipt of an official acceptance notice from China's National Medical Products Administration for its clinical trial application of the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","IBBJ","BK0239","PSYK","300199","IBBQ","BK0070","BMED","BK0077","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103728541","title":"AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1103728541","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103728541?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:26","pubTimestamp":1789000007,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced that its lead artificial intelligence-powered investigational drug, Rentosertib (also known as ISM001-055/INS018_055), has achieved a significant clinical milestone...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQX","03086","MDTX","06978","CPNQ","09834","TARK","BK4593","NJUL","QQA","NOCT","161631","NBDS","QQQ","VUSE","AIBU","SQQQ","QTOC","07266","BK1574","CWC","BMED","OGIG","AGIX","03455","AIQU","QQQM","QDEC","DQJN","03034","FWD","BK1141","TECY","QLD","07568","TQQY","IBBQ","PBOT","PSYK","03696","QMAR","02834","AQGX","WPAI","GK","MVPS","09086","07522","CHAT","NAPR","PSQ","07261","QSWN","LNGR","QID","GPIQ","IBBJ","AIFD","MEDX","LCLG","ARTY","NJAN","BK1161","NEWZ","TQQQ","KOMP","159992","MFIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530163","title":"Bank of America Reveals 5.22% Indirect Stake in Qiagen","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530163","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530163?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:37","pubTimestamp":1788986261,"startTime":"0","endTime":"0","summary":"Qiagen ( ($QGEN) ) has issued an update. QIAGEN N.V., a Netherlands-based life sciences and biotechnology group focused on molecular diagnostics an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FNCL","LU0314106906.USD","LU0321505868.SGD","BK4581","BMED","IBB","IE00B1BXHZ80.USD","LU0256863902.USD","LU1894683264.USD","LU0070302665.USD","XT","LU2129689431.USD","LU0130517989.USD","LU1280957306.USD","LU1496350502.SGD","SYNB","UYG","AGNG","IE00BKVL7J92.USD","LNGR","TFNS","LU2133065610.SGD","LU1718418525.SGD","PGF","IEIH","DARP","LU1366192091.USD","BBP","BAC","JDOC","XLF","KBWB","RSPH","FTXO","LU1804176565.USD","FHLC","IYF","LU0648000940.SGD","BK4534","FWD","LU0648001328.SGD","LU0208291251.USD","VFH","IE00B19Z3581.USD","HTEC","IYG","LU0256863811.USD","GNMX","HELX","BK4582"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666531778","title":"Merck Price Target Raised to $161.00/Share from $127.00 by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2666531778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666531778?lang=en_us&edition=fundamental","pubTime":"2026-09-10 00:13","pubTimestamp":1788970380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MRK/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU1035773651.USD","LU0965509010.AUD","LU1066051225.USD","LU0130102774.USD","MRK","IE00B4R5TH58.HKD","LU0868494708.USD","LU0130517989.USD","TRUH","LU2361044865.SGD","LU1941712264.USD","LU1066051498.USD","IE00BSNM7G36.USD","JDOC","LU2125154778.USD","IE000M9KFDE8.USD","LU0965508806.USD","BMED","BK4588","IE00B2B36J28.USD","LU0106261372.USD","LU2361045086.USD","SG9999014542.SGD","BK4007","RXL","LU0211331839.USD","LU0320765646.SGD","LU1983299246.USD","LU2461242641.AUD","LU2112291526.USD","LU0124676726.USD","SG9999002232.USD","IE0009355771.USD","LU1037948541.HKD","LU1201861249.SGD","SG9999014567.USD","LU0006306889.USD","LU0477156953.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1093756168.USD","XLV","SG9999015341.SGD","BK4534","IE00BN8TJ469.HKD","LU1291159041.SGD","IE00BFTCPJ56.SGD","PPH","LU1923622614.USD","LU2357627491.SGD","SG9999015358.SGD","LU1057294990.SGD","LU0058720904.USD","HRTS","FTXH","IE00BJT1NW94.SGD","LU1066051811.HKD","SGXZ57979304.SGD","LU2324357040.USD","LU1699723380.USD","LU2106854487.HKD","LU1917777945.USD","SG9999014559.SGD","LU0942090050.USD","LU2491050071.SGD","LU2125909247.SGD","LU0965509283.SGD","BK4533","SG9999013999.USD","LU0868494617.USD","LU0203347892.USD","LU0265550359.USD","SG9999001440.SGD","LU0234572021.USD","LU2125909593.SGD","LU0689626769.HKD","LU1069347547.HKD","LU0985320562.USD","LU0266013472.USD","LU0965509101.SGD","LU2433249047.HKD","IE0002141913.USD","LU2491049909.HKD","LU1934455277.USD","LU1974910355.USD","IYH","LU2361044949.HKD","FHLC","LU0289739699.SGD","SG9999001176.USD","LU1941712348.USD","LU1162221912.USD","LU0238689110.USD","LU1116320901.HKD","IE00BBT3K403.USD","LU0208291251.USD","SG9999001176.SGD","LU0980610538.SGD","IE00B1BXHZ80.USD","LU0320765489.SGD","SG9999014575.USD","LU2360032135.SGD","IE00BLSP4239.USD","LU2491050154.USD","BK4516","LU2089984988.USD","IHE","LU0098860793.USD","LU1032466523.USD","LU1989772923.USD","LU0861579265.USD","LU1989772840.SGD","IE00BLSP4452.SGD","LU1571399168.USD","SG9999002224.SGD","LU1585245621.USD","LU0823416689.USD","IXJ","PAWZ","LU1989771016.USD","LU2468319806.SGD","LU1929549753.HKD","LU0648001328.SGD","LU1934455863.HKD","VHT","GDOC","LU1061106388.HKD","LU0122379950.USD","LU2023250843.SGD","LU0859254822.USD","BK4550","LU1093756325.SGD","LU2125154935.USD","LU1430594728.SGD","LU0203345920.USD","LU1037948897.HKD","LU1934455194.USD","LU1116320737.USD","LU1066053197.SGD","LU0265550946.USD","BK4559","LU0070302665.USD","BK4585","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666253912","title":"Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666253912","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666253912?lang=en_us&edition=fundamental","pubTime":"2026-09-09 22:44","pubTimestamp":1788965040,"startTime":"0","endTime":"0","summary":"Tyra Biosciences is taking on Johnson & Johnson to develop a next-generation treatment common type of bladder cancer, but the latest data for its experimental pill failed to inspire confidence.The Pha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703178.SGD","BK4532","JNJ","SGXZ80539844.SGD","LU1196500208.SGD","LU2213496289.HKD","IE000SO60NU8.SGD","FTXH","LU0289739699.SGD","SG9999002224.SGD","LU1043141123.HKD","TYRA","IE000F7OJYX1.SGD","IE000M9KFDE8.USD","LU0122379950.USD","XLV","IYH","LU1291159041.SGD","IE00BLSP4239.USD","LU0203347892.USD","LU1914381329.SGD","SG9999002232.USD","IXJ","BK4550","LU1280957306.USD","IE0009355771.USD","RXL","LU0203345920.USD","URGN","LU0426417589.USD","IE00B7SZLL34.SGD","PJP","SGXZ57979304.SGD","MEDX","IE00BFXG1179.USD","VHT","BK4139","BMED","IHE","LU1244550577.SGD","LU1551013342.USD","LU1032466523.USD","LU2468319806.SGD","LU2403377893.USD","LU2750360641.GBP","LU2756315664.SGD","FHLC","JDOC","TRUH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666858794","title":"Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666858794","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666858794?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Sept.  09, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358477/24675/en/fate-therapeutics-announces-encore-clinical-data-presentation-of-ft819-off-the-shelf-car-t-cell-product-candidate-at-the-ccr-west-2026-meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","BMED","MEDX","SLE","BK4139","NVIB","HYLG","CCR","IDNA","FATE","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666558799","title":"Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247","url":"https://stock-news.laohu8.com/highlight/detail?id=2666558799","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666558799?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"TORONTO, Sept.  09, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience (Nasdaq: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358479/0/en/satellos-announces-forazapadin-as-assigned-international-nonproprietary-name-for-lead-drug-candidate-sat-3247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAT","GDOC","DBB","BMED","HYLG","INN","IDNA","MEDX","BK4181","NVIB","BK4218"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666821375","title":"Leerink Partners Adjusts Price Target on Merck & Co. to $161 From $127, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666821375","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666821375?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:47","pubTimestamp":1788950858,"startTime":"0","endTime":"0","summary":"Merck & Co. (MRK) has an average rating of overweight and mean price target of $150.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765489.SGD","LU1037948541.HKD","LU2125909247.SGD","LU2324357040.USD","MRK","SG9999014542.SGD","HRTS","LU0861579265.USD","LU0098860793.USD","SG9999014567.USD","LU0965509010.AUD","LU0211331839.USD","LU0985320562.USD","IXJ","LU0234572021.USD","IE00BSNM7G36.USD","LU0238689110.USD","LU0106261372.USD","SGXZ57979304.SGD","LU2491050154.USD","LU0130517989.USD","FTXH","LU2125154935.USD","IYH","LU2361044865.SGD","IE00BJT1NW94.SGD","LU0070302665.USD","LU1162221912.USD","LU0477156953.USD","LU2360032135.SGD","LU1585245621.USD","LU0689626769.HKD","LU1037948897.HKD","SG9999002232.USD","LU0965509101.SGD","GDOC","BK4585","LU1093756168.USD","IE00BLSP4239.USD","LU1093756325.SGD","LU1291159041.SGD","LU0124676726.USD","LU1032466523.USD","LU2491049909.HKD","SG9999014559.SGD","LU1923622614.USD","LU0203347892.USD","LU0265550359.USD","SG9999001176.SGD","LU2023250843.SGD","LU1066051225.USD","LU1699723380.USD","SG9999015358.SGD","LU1069347547.HKD","LU2112291526.USD","LU1023059063.AUD","LU1934455194.USD","SG9999015341.SGD","LU2491050071.SGD","IE00BBT3K403.USD","LU1941712348.USD","LU0942090050.USD","LU0868494617.USD","BK4559","BK4550","LU1929549753.HKD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU1917777945.USD","LU1989772923.USD","LU1934455277.USD","LU1116320737.USD","SG9999001176.USD","IE0009355771.USD","LU1066053197.SGD","LU0130102774.USD","IE00B2B36J28.USD","LU1989771016.USD","LU1430594728.SGD","BK4534","LU1974910355.USD","TRUH","LU2357627491.SGD","LU1066051498.USD","LU0266013472.USD","LU1571399168.USD","LU0203345920.USD","FHLC","LU1989772840.SGD","LU0648001328.SGD","LU1035773651.USD","LU1941712264.USD","LU0208291251.USD","LU1116320901.HKD","JDOC","IE00B1BXHZ80.USD","IHE","LU0432979614.USD","SG9999013999.USD","BK4007","SG9999002224.SGD","LU0122379950.USD","IE0002141913.USD","LU2361045086.USD","BMED","IE000M9KFDE8.USD","LU1934455863.HKD","BK4588","LU1057294990.SGD","LU2089984988.USD","LU2461242641.AUD","BK4533","LU0980610538.SGD","LU0265550946.USD","IE00BLSP4452.SGD","LU2125909593.SGD","IE00BN8TJ469.HKD","LU1983299246.USD","SG9999014575.USD","LU2433249047.HKD","LU2106854487.HKD","LU0320765646.SGD","RXL","LU0859254822.USD","XLV","BK4516","IE00BJJMRZ35.SGD","PPH","LU0868494708.USD","LU0823416689.USD","LU2361044949.HKD","LU0006306889.USD","LU2023250504.SGD","PAWZ","SG9999001440.SGD","LU1061106388.HKD","LU0965508806.USD","LU0965509283.SGD","LU1066051811.HKD","VHT","LU2125154778.USD","LU0058720904.USD","LU0289739699.SGD","LU2468319806.SGD","LU1201861249.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666258492","title":"Merck & Co Inc : Leerink Partners Raises Target Price to $161 from $127","url":"https://stock-news.laohu8.com/highlight/detail?id=2666258492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666258492?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:17","pubTimestamp":1788949066,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN4510IW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2491049909.HKD","LU0868494617.USD","LU0211331839.USD","LU0648001328.SGD","LU0965508806.USD","LU2468319806.SGD","LU1032466523.USD","LU2023250504.SGD","BK4007","LU2357627491.SGD","SG9999014542.SGD","LU0432979614.USD","LU0130102774.USD","LU1201861249.SGD","LU0203347892.USD","LU1983299246.USD","IE00BSNM7G36.USD","LU0122379950.USD","TRUH","LU1934455277.USD","LU2112291526.USD","IE00BBT3K403.USD","LU2433249047.HKD","IE00B2B36J28.USD","SG9999015358.SGD","LU2089984988.USD","LU2106854487.HKD","SG9999002232.USD","LU0689626769.HKD","LU1116320901.HKD","LU0965509101.SGD","LU1066051811.HKD","SG9999014575.USD","LU1941712264.USD","HRTS","XLV","JDOC","LU0124676726.USD","BK4533","IHE","SG9999001176.SGD","LU0320765489.SGD","LU0289739699.SGD","LU2361044949.HKD","LU0106261372.USD","LU0266013472.USD","LU2125909247.SGD","LU0868494708.USD","SG9999014559.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1923622614.USD","SG9999002224.SGD","BK4550","SG9999014567.USD","LU1093756325.SGD","BK4534","FHLC","IE00B4R5TH58.HKD","LU0234572021.USD","LU1699723380.USD","LU0965509283.SGD","SG9999001440.SGD","LU2023250843.SGD","BK4559","LU2125154935.USD","LU0823416689.USD","LU1037948897.HKD","LU2324357040.USD","LU1571399168.USD","IYH","IE00BLSP4239.USD","LU2361044865.SGD","LU2491050154.USD","LU1037948541.HKD","LU0006306889.USD","LU0058720904.USD","BK4516","LU0203345920.USD","LU1162221912.USD","BK4588","LU1061106388.HKD","LU0859254822.USD","LU0980610538.SGD","PPH","GDOC","LU1066051498.USD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","LU1066051225.USD","SG9999015341.SGD","LU0070302665.USD","LU1989771016.USD","LU1069347547.HKD","VHT","LU0208291251.USD","LU0265550946.USD","LU0985320562.USD","LU2491050071.SGD","SG9999013999.USD","IE00BN8TJ469.HKD","LU1023059063.AUD","IE0009355771.USD","LU0265550359.USD","LU1430594728.SGD","LU2125909593.SGD","LU1291159041.SGD","LU0965509010.AUD","LU1974910355.USD","LU0942090050.USD","BK4585","LU1941712348.USD","LU2361045086.USD","IXJ","LU1093756168.USD","LU0477156953.USD","IE000M9KFDE8.USD","MRK","LU1989772840.SGD","LU1934455194.USD","LU1057294990.SGD","LU0320765646.SGD","BMED","LU1585245621.USD","LU1116320737.USD","LU1929549753.HKD","LU1035773651.USD","LU0098860793.USD","LU0130517989.USD","LU0238689110.USD","RXL","FTXH","LU1917777945.USD","PAWZ","SG9999001176.USD","SGXZ57979304.SGD","LU1989772923.USD","LU2125154778.USD","LU1066053197.SGD","LU2360032135.SGD","LU2461242641.AUD","LU1934455863.HKD","IE0002141913.USD","IE00BLSP4452.SGD","LU0861579265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151768833","title":"CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1151768833","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151768833?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:12","pubTimestamp":1788948739,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its self-developed gonadotropin-releasing hormone (GnRH) receptor agonist, Goserelin Extended-Release Injection (SYH9102 Injection), has received approval from...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","LU1960683339.HKD","LU1226287875.USD","KURE","LU0067412154.USD","LU1328277881.USD","LU1152091168.USD","LU1226287529.USD","IE00B031HY20.USD","LU0314109678.HKD","LU0880133367.SGD","LU1951186391.HKD","BK1521","LU0072913022.USD","BMED","IE00BZ08YR35.GBP","LU0501845795.SGD","LU1008478684.HKD","LU0326950275.SGD","LU1226288170.HKD","PSYK","LU1152091754.HKD","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","LU1807302812.USD","LU0315179316.USD","LU0140636845.USD","LU2039709279.SGD","BK1515","LU1226287792.SGD","IE00B543WZ88.USD","BK1191","01093","IBBQ","LU1993786604.SGD","MDTX","LU1813983027.USD","LU1226288253.USD","SG9999004220.SGD","IE00BZ08YS42.EUR","IE0008368742.USD","IE0008369823.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100647125","title":"CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1100647125","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100647125?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:12","pubTimestamp":1788948739,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its self-developed gonadotropin-releasing hormone (GnRH) receptor agonist, Goserelin Extended-Release Injection (SYH9102 Injection), has received approval from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","LU1152091754.HKD","MDTX","KURE","IBBJ","IE00B5MMRT66.SGD","HK0000165453.HKD","LU0315179316.USD","SG9999004220.SGD","01093","LU0314109678.HKD","LU1226287792.SGD","LU1226288170.HKD","PSYK","LU1152091168.USD","BK1521","IE0008368742.USD","IE0008369823.USD","BMED","LU1813983027.USD","IE00BZ08YT58.USD","LU0140636845.USD","BK1515","IE00BZ08YR35.GBP","LU1807302812.USD","LU1328277881.USD","BK1191","LU1226288253.USD","LU0067412154.USD","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1951186391.HKD","LU1226287529.USD","LU1008478684.HKD","IE00B031HY20.USD","LU1993786604.SGD","LU0072913022.USD","LU2039709279.SGD","LU1226287875.USD","IBBQ","IE00B543WZ88.USD","LU0501845795.SGD","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666450584","title":"Merck price target raised to $161 from $127 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2666450584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666450584?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:10","pubTimestamp":1788948612,"startTime":"0","endTime":"0","summary":"Leerink raised the firm’s price target on Merck (MRK) to $161 from $127 and keeps an Outperform rating on the shares. Published first on TheFly – t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-price-target-raised-to-161-from-127-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-price-target-raised-to-161-from-127-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2361045086.USD","LU2433249047.HKD","LU0477156953.USD","IE0009355771.USD","RXL","SG9999013999.USD","IYH","LU1291159041.SGD","LU0106261372.USD","LU1162221912.USD","LU1430594728.SGD","LU0320765646.SGD","LU0320765489.SGD","LU2125909593.SGD","LU0965509010.AUD","IE00BJT1NW94.SGD","PAWZ","LU1066053197.SGD","LU1941712264.USD","LU1941712348.USD","LU2360032135.SGD","LU1037948897.HKD","LU1989772840.SGD","BK4550","LU0208291251.USD","BMED","IE00BLSP4452.SGD","LU2023250843.SGD","LU1699723380.USD","LU0965508806.USD","LU2461242641.AUD","IE0002141913.USD","LU0648001328.SGD","SG9999001176.SGD","SG9999014559.SGD","SG9999002232.USD","LU0122379950.USD","LU0859254822.USD","HRTS","FTXH","LU2468319806.SGD","LU1201861249.SGD","IE00B1BXHZ80.USD","LU2106854487.HKD","LU0942090050.USD","LU0861579265.USD","IXJ","LU1983299246.USD","LU0868494708.USD","LU0203345920.USD","PPH","LU1974910355.USD","LU1093756325.SGD","LU0985320562.USD","LU1929549753.HKD","LU2112291526.USD","IE00B4R5TH58.HKD","BK4588","MRK","LU0689626769.HKD","FHLC","BK4516","LU0124676726.USD","LU1989772923.USD","BK4534","LU0266013472.USD","LU0234572021.USD","BK4007","LU0980610538.SGD","IE00BBT3K403.USD","LU1093756168.USD","TRUH","LU2361044949.HKD","SG9999015341.SGD","LU0238689110.USD","LU0432979614.USD","LU0868494617.USD","LU1035773651.USD","LU1585245621.USD","SG9999001176.USD","LU1061106388.HKD","BK4585","LU2125154935.USD","LU1066051225.USD","SG9999002224.SGD","LU1032466523.USD","LU1057294990.SGD","LU1066051811.HKD","LU0265550359.USD","LU2491050071.SGD","LU1069347547.HKD","LU1934455194.USD","JDOC","LU0289739699.SGD","LU2324357040.USD","XLV","LU1571399168.USD","IE00BN8TJ469.HKD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU1923622614.USD","BK4533","SG9999015358.SGD","LU2125154778.USD","LU2361044865.SGD","SG9999014575.USD","LU0130517989.USD","LU1116320737.USD","LU0265550946.USD","IE00BFTCPJ56.SGD","LU0006306889.USD","SG9999014567.USD","LU0965509283.SGD","GDOC","IHE","LU1989771016.USD","IE00BSNM7G36.USD","LU0203347892.USD","LU1066051498.USD","LU2089984988.USD","LU0965509101.SGD","LU1934455277.USD","LU1037948541.HKD","BK4559","IE00BJJMRZ35.SGD","LU2023250504.SGD","SG9999001440.SGD","IE000M9KFDE8.USD","LU0130102774.USD","SG9999014542.SGD","LU2491050154.USD","LU1934455863.HKD","LU1116320901.HKD","LU0058720904.USD","LU1917777945.USD","IE00B2B36J28.USD","LU0211331839.USD","LU2491049909.HKD","LU0098860793.USD","LU2357627491.SGD","LU2125909247.SGD","LU1023059063.AUD","VHT","LU0823416689.USD","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666307256","title":"Genfit Targets Billion‑Dollar MASH Diagnostics Market With NISTM Blood Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2666307256","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666307256?lang=en_us&edition=fundamental","pubTime":"2026-09-09 14:17","pubTimestamp":1788934629,"startTime":"0","endTime":"0","summary":"Genfit ( ($FR:GNFT) ) has issued an announcement. Genfit is sharpening its focus on non‑invasive diagnostics for MASLD and MASH, aiming to replace ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genfit-targets-billiondollar-mash-diagnostics-market-with-nistm-blood-tests?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genfit-targets-billiondollar-mash-diagnostics-market-with-nistm-blood-tests?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF","BMED","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666237038","title":"Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666237038","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666237038?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:58","pubTimestamp":1788901080,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  slipped 3.77% to $212.50 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's second consecutive day of losses.Biogen Inc. closed 5.89% short of its 52-week high of $225.80, which the company reached on September 3rd.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Pfizer Inc.  fell 2.32% to $27.79, and AbbVie Inc.  fell 2.99% to $248.78.Trading volume  remained 492,227 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IE00B19Z9Z06.USD","BK4588","BMED","BK4585","IE00B894F039.SGD","LU0320765992.SGD","PBE","BIIB","LU0889565916.HKD","BK4532","LU0109394709.USD","LU0234570918.USD","BK4139","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}